The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review
Open Access
- 8 September 2024
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 23 (10) , 103637
Abstract
No abstract availableKeywords
This publication has 105 references indexed in Scilit:
- The role of the CX3CL1/CX3CR1 axis as potential inflammatory biomarkers in subjects with periodontitis and rheumatoid arthritis: A systematic reviewImmunity, Inflammation and Disease, 2024
- PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patientsInflammopharmacology, 2023
- Expansion of Fcγ Receptor IIIa–Positive Macrophages, Ficolin 1–Positive Monocyte‐Derived Dendritic Cells, and Plasmacytoid Dendritic Cells Associated With Severe Skin Disease in Systemic SclerosisArthritis & Rheumatology, 2022
- Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX3CL1/CX3CR1 Pathway in Experimental Mouse Models of Systemic SclerosisArthritis & Rheumatology, 2019
- Macrophages in Systemic Sclerosis: Novel Insights and Therapeutic ImplicationsCurrent Rheumatology Reports, 2019
- M2 macrophages induce EMT through the TGF‐β/Smad2 signaling pathwayCell Biology International, 2017
- Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?Current Rheumatology Reports, 2015
- Fibrosis, Vascular Activation, and Immune Abnormalities Resembling Systemic Sclerosis in Bleomycin‐Treated Fli‐1–Haploinsufficient MiceArthritis & Rheumatology, 2014
- Macrophage plasticity and polarization in tissue repair and remodellingThe Journal of Pathology, 2012
- Serum levels of soluble CD163 in patients with systemic sclerosisRheumatology International, 2010